DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Building BlocksBuilding Blocks
  4. /Heterocyclic ScaffoldsHeterocyclic Scaffolds
  5. /ImidazolesImidazoles
  6. /2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamideCAS 152721-37-4
Chemical structure of CAS 152721-37-4

2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide

In Stock•Starting at $37 for 1 mg
CAS No.152721-37-4
MDL No.MFCD18450236
MFC8H7F5N4O3
MW302.16
InChI KeyJGGDSDPOPRWSCX-UHFFFAOYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT→

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mgTo Be Confirmed$37In Stock
5 mgTo Be Confirmed$86In Stock
10 mgTo Be Confirmed$140In Stock
25 mgTo Be Confirmed$282In Stock
50 mgTo Be Confirmed$450In Stock
100 mgTo Be Confirmed$643In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.152721-37-4
Product Name2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide
Heavy Atom Count20Rotatable Bond Count5
Atom Stereo Count0Bond Stereo Count0
HBA5HBD1
TPSA90.060 ŲCharge0
Exact Mass302.04383Complexity512.46
pKa6.008XLogP1.105

Related Articles

Studies related to this compound and its mechanism of action

[18F]-EF5, a marker for PET detection of hypoxia: synthesis of precursor and a new fluorination procedure.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine • Vol. 54, Issue 1 • 2001
PMID: 11144255DOI: 10.1016/s0969-8043(00)00102-0

Influence of hydralazine administration on oxygenation in spontaneous and transplanted tumor models.

International journal of radiation oncology, biology, physics • Vol. 49, Issue 3 • 2001
PMID: 11172963DOI: 10.1016/s0360-3016(00)01400-0

Hypoxia in human intraperitoneal and extremity sarcomas.

International journal of radiation oncology, biology, physics • Vol. 49, Issue 2 • 2001
PMID: 11173159DOI: 10.1016/s0360-3016(00)01494-2

Hypoxia in radiation-induced blood-spinal cord barrier breakdown.

Cancer research • Vol. 61, Issue 8 • 2001
PMID: 11309291

Documentation

Similar Products

  • Benznidazole

    CAS No.22994-85-0

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact